Simonetti R G, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R
Istituto di Medicina Generale e Pneumologia, University of Palermo, Italy.
Ann Intern Med. 1992 Jan 15;116(2):97-102. doi: 10.7326/0003-4819-116-2-97.
To determine whether chronic hepatitis C virus (HCV) infection is an independent risk factor for hepatocellular carcinoma and whether it increases the cirrhosis-related risk for hepatocellular carcinoma.
Two pair-matched case-control studies.
A referral-based hospital.
In study I, 212 patients with hepatocellular carcinoma (197 of whom had known underlying cirrhosis) were compared with controls who had chronic nonhepatic diseases. In study II, the 197 patients with hepatocellular carcinoma and cirrhosis were compared with 197 pair-matched controls who had cirrhosis but not hepatocellular carcinoma.
Levels of antibody to HCV (anti-HCV), hepatitis B surface antigen (HBsAg), and antibody to hepatitis B core antigen (anti-HBc) were assayed, and alcohol abuse was assessed by history.
In study I, 151 patients (71%) with hepatocellular carcinoma were anti-HCV positive compared with 11 controls (5%) with chronic nonhepatic diseases (odds ratio, 42; 95% CI, 22 to 95). Multivariate analysis showed that anti-HCV was an independent risk factor for hepatocellular carcinoma (odds ratio, 69; CI, 15 to 308). The analysis also showed that HBsAg (odds ratio, 8.7; CI, 1.5 to 50) and anti-HBc (odds ratio, 4.2 (CI, 1.7 to 11) were risk factors for hepatocellular carcinoma. No statistically significant interaction was found between anti-HCV and the markers of HBV infection. In study II, 146 patients (74%) with hepatocellular carcinoma and cirrhosis were anti-HCV positive compared with 122 patients (62%) with cirrhosis alone (odds ratio, 1.8; CI, 1.1 to 2.8). Multivariate analysis confirmed that anti-HCV (odds ratio, 2.0; CI, 1.3 to 32) and HBsAg (odds ratio, 2.0; CI, 1.0 to 4.2) were independent risk factors for hepatocellular carcinoma.
Hepatitis C virus infection is a risk factor for hepatocellular carcinoma, apparently by inducing cirrhosis and, to a lesser extent, by enhancing the risk in patients with cirrhosis. Hepatitis C virus infection acts independently of HBV infection (another risk factor) and of alcohol abuse, age, or gender.
确定慢性丙型肝炎病毒(HCV)感染是否为肝细胞癌的独立危险因素,以及它是否增加与肝硬化相关的肝细胞癌风险。
两项配对病例对照研究。
一家转诊医院。
在研究I中,将212例肝细胞癌患者(其中197例已知有潜在肝硬化)与患有慢性非肝脏疾病的对照组进行比较。在研究II中,将197例患有肝细胞癌和肝硬化的患者与197例配对的有肝硬化但无肝细胞癌的对照组进行比较。
检测HCV抗体(抗-HCV)、乙肝表面抗原(HBsAg)和乙肝核心抗原抗体(抗-HBc)水平,并通过病史评估酒精滥用情况。
在研究I中,151例(71%)肝细胞癌患者抗-HCV阳性,而11例(5%)患有慢性非肝脏疾病的对照组患者抗-HCV阳性(比值比,42;95%可信区间,22至95)。多变量分析显示,抗-HCV是肝细胞癌的独立危险因素(比值比,69;可信区间,15至308)。分析还显示,HBsAg(比值比,8.7;可信区间,1.5至50)和抗-HBc(比值比,4.2;可信区间,1.7至11)是肝细胞癌的危险因素。未发现抗-HCV与HBV感染标志物之间有统计学显著的相互作用。在研究II中,146例(74%)患有肝细胞癌和肝硬化的患者抗-HCV阳性,而仅患有肝硬化的122例患者(62%)抗-HCV阳性(比值比,1.8;可信区间,1.1至2.8)。多变量分析证实,抗-HCV(比值比,2.0;可信区间,1.3至3.2)和HBsAg(比值比,2.0;可信区间,1.0至4.2)是肝细胞癌的独立危险因素。
丙型肝炎病毒感染是肝细胞癌的危险因素,显然是通过诱发肝硬化,在较小程度上是通过增加肝硬化患者的风险。丙型肝炎病毒感染独立于HBV感染(另一个危险因素)以及酒精滥用、年龄或性别起作用。